Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warick Delprado

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
BJU International|July 10, 2019
Diagnostic accuracy of <sup>68</sup> Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of <sup>68</sup> Ga-PSMA PET to mpMRIMatthijs J Scheltema, John I Chang, Phillip D Stricker, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 20, 2016
Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional studyShoshana B Ginsburg, Ahmad Algohary, Shivani Pahwa, et al.
Urology|July 8, 2022
Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node DissectionHilda A de Barros, Sebastiaan Remmers, Henk B Luiting, et al.
International Journal of Cancer|October 6, 2018
An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomyAlison Y Zhang, Karen Chiam, Ygal Haupt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2006
Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosisKrishan K Rasiah, James G Kench, Margaret Gardiner-Garden, et al.
BJU International|October 20, 2023
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapyBart Geboers, Dennie Meijer, William Counter, et al.
Oncogene|September 5, 2003
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancerSusan M Henshall, Daniel E H Afar, Krishan K Rasiah, et al.
The Lancet. Oncology|October 1, 2020
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trialAndrew Kneebone, Carol Fraser-Browne, Gillian M Duchesne, et al.
European Urology Focus|July 30, 2017
Development of Indicators to Assess Quality of Care for Prostate CancerNupur Nag, Jeremy Millar, Ian D Davis, et al.
American Journal of Clinical Pathology|December 25, 2024
Urothelial carcinoma in situ with "early papillary formation" vs "lateral spread/shoulder lesion" of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretationsAnkur R Sangoi, Ali Shahabi, Michelle S Hirsch, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
BJU International|July 10, 2019
Diagnostic accuracy of <sup>68</sup> Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of <sup>68</sup> Ga-PSMA PET to mpMRIMatthijs J Scheltema, John I Chang, Phillip D Stricker, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 20, 2016
Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional studyShoshana B Ginsburg, Ahmad Algohary, Shivani Pahwa, et al.
Urology|July 8, 2022
Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node DissectionHilda A de Barros, Sebastiaan Remmers, Henk B Luiting, et al.
International Journal of Cancer|October 6, 2018
An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomyAlison Y Zhang, Karen Chiam, Ygal Haupt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2006
Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosisKrishan K Rasiah, James G Kench, Margaret Gardiner-Garden, et al.
BJU International|October 20, 2023
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapyBart Geboers, Dennie Meijer, William Counter, et al.
Oncogene|September 5, 2003
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancerSusan M Henshall, Daniel E H Afar, Krishan K Rasiah, et al.
The Lancet. Oncology|October 1, 2020
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trialAndrew Kneebone, Carol Fraser-Browne, Gillian M Duchesne, et al.
European Urology Focus|July 30, 2017
Development of Indicators to Assess Quality of Care for Prostate CancerNupur Nag, Jeremy Millar, Ian D Davis, et al.
American Journal of Clinical Pathology|December 25, 2024
Urothelial carcinoma in situ with "early papillary formation" vs "lateral spread/shoulder lesion" of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretationsAnkur R Sangoi, Ali Shahabi, Michelle S Hirsch, et al.
Pageof 8